SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Ardelyx, Inc. (ARDX)

Add ARDX Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 8/19/2016 4:48:54 PM - Followers: 0 - Board type: Free - Posts Today: 0
Ardelyx, Inc.
34175 Ardenwood Boulevard
Suite 100
Fremont, CA 94555
United States
Phone: 510-745-1700
Fax: 510-745-0493

Ardelyx, Inc. discovers, develops, and commercializes minimally-systemic small molecule therapeutics for the gastrointestinal (GI) tract to treat cardio-renal, GI, and metabolic diseases. Its lead product candidate is tenapanor, a small molecule NHE3 inhibitor, which has completed Phase 2b clinical trial for the treatment of patients with constipation-predominant irritable bowel syndrome and hyperphosphatemic patients with chronic kidney disease on dialysis, as well as Phase 2a clinical trial in patiets with late-stage chronic kidney disease. The company’s discovery and lead development programs that are in research phase include RDX002 NaP2b inhibitor for hyperphosphatemia; RDX009 TGR5 agonists for inflammatory bowel disease, short bowel syndrome, and non-alcoholic steatohepatitis; and RDX013 for hyperkalemia. It has a collaboration partnership agreement with AstraZeneca AB for the development and commercialization of tenapanor. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ARDX News: Statement of Changes in Beneficial Ownership (4) 10/26/2016 07:11:25 PM
ARDX News: Initial Statement of Beneficial Ownership (3) 10/26/2016 07:09:54 PM
ARDX News: Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer 10/24/2016 07:00:00 AM
ARDX News: Ardelyx Announces the Presentation of Positive Global Endpoint Findings from Phase 2b Trial of Tenapanor in Patients with IBS... 10/19/2016 07:00:00 AM
ARDX News: Statement of Changes in Beneficial Ownership (4) 10/13/2016 07:40:34 PM
#4   ARDX bullish 9.19 stocktrademan 08/19/16 04:48:54 PM
#3   ARDX bullish 10.375 stocktrademan 08/16/16 10:24:42 AM
#2   ARDX bullish 11.00 stocktrademan 07/21/16 01:09:59 PM
#1   $ARDX recent news/filings stocktrademan 11/25/15 02:11:45 PM